Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?
For a full list of eligibility, visit BMS Study Connect.
For a full list of exclusion criteria, visit BMS Study Connect.
Please contact the sites directly. If there is no contact information, email Clinical.Trials@bms.com
This study is researching immunotherapy drugs for treating advanced cancers. The researchers are studying whether treatment with a combination of the drugs nivolumab plus ipilimumab is safe and effective compared with nivolumab alone.
This study is also researching whether a tumor test called "tumor mutational burden" (TMB) can help doctors tell how well patients will respond to immunotherapy drugs.
This is a randomized, two-arm study.